E.C. Smyth

Predictive role of microsatellite instability for PD-1 blockade in patients with advanced gastric cancer: a meta-analysis of randomized clinical trials

Filippo Pietrantonio, Giovanni Randon, Maria Di Bartolomeo et al. · ESMO Open · 2021 · 194 citations · Full text

Medicine, Immunology, Oncology +16

1205MO Updated analysis of DESTINY-Gastric02: A phase II single-arm trial of trastuzumab deruxtecan (T-DXd) in western patients (Pts) with HER2-positive (HER2+) unresectable/metastatic gastric/gastroesophageal junction (GEJ) cancer who progressed on or after trastuzumab-containing regimen

Geoffrey Y. Ku, Maria Di Bartolomeo, E.C. Smyth et al. · Annals of Oncology · 2022 · 30 citations · Full text

Medicine, Oncology, Metastasis +16

LBA55 Primary analysis of a phase II single-arm trial of trastuzumab deruxtecan (T-DXd) in western patients (Pts) with HER2-positive (HER2+) unresectable or metastatic gastric or gastroesophageal junction (GEJ) cancer who progressed on or after a trastuzumab-containing regimen

Eric Van Cutsem, Maria Di Bartolomeo, E.C. Smyth et al. · Annals of Oncology · 2021 · 28 citations

Medicine, Oncology, Pharmacotherapy +17

LBA81 Final overall survival (OS) and the association of pathological outcomes with event-free survival (EFS) in MATTERHORN: A randomised, phase III study of durvalumab (D) plus 5-fluorouracil, leucovorin, oxaliplatin and docetaxel (FLOT) in resectable gastric / gastroesophageal junction (G / GEJ) adenocarcinoma

J. Tabernero, S-E. Al-Batran, Zev A. Wainberg et al. · Annals of Oncology · 2025 · 10 citations

Medicine, Oncology, Pathology +9